MX2009007384A - Formulaciones que contienen ?-lactama con elevada estabilidad en disolucion acuosa. - Google Patents

Formulaciones que contienen ?-lactama con elevada estabilidad en disolucion acuosa.

Info

Publication number
MX2009007384A
MX2009007384A MX2009007384A MX2009007384A MX2009007384A MX 2009007384 A MX2009007384 A MX 2009007384A MX 2009007384 A MX2009007384 A MX 2009007384A MX 2009007384 A MX2009007384 A MX 2009007384A MX 2009007384 A MX2009007384 A MX 2009007384A
Authority
MX
Mexico
Prior art keywords
lactam
aqueous solution
increased stability
containing formulations
formulations
Prior art date
Application number
MX2009007384A
Other languages
English (en)
Inventor
Dirk Mertin
Bernd Bigalke
Franz Pirro
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of MX2009007384A publication Critical patent/MX2009007384A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/195Antibiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/10Feeding-stuffs specially adapted for particular animals for ruminants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/60Feeding-stuffs specially adapted for particular animals for weanlings
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/70Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75Feeding-stuffs specially adapted for particular animals for birds for poultry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

La invención se refiere a nuevas formulaciones para disolver en agua que contienen un antibiótico 3-lactámico y urea y cuyo valor de pH después de disolver la formulación en agua se encuentra en el intervalo de 4,5 a 8. Las formulaciones son especialmente adecuadas para el tratamiento de animales contra enfermedades bacterianas.
MX2009007384A 2007-01-19 2008-01-10 Formulaciones que contienen ?-lactama con elevada estabilidad en disolucion acuosa. MX2009007384A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007002924A DE102007002924A1 (de) 2007-01-19 2007-01-19 ß-Lactam-haltige Formulierungen mit erhöhter Stabilität in wässriger Lösung
PCT/EP2008/000125 WO2008086971A2 (de) 2007-01-19 2008-01-10 β-LACTAM-HALTIGE FORMULIERUNGEN MIT ERHÖHTER STABILITÄT IN WÄSSRIGER LÖSUNG

Publications (1)

Publication Number Publication Date
MX2009007384A true MX2009007384A (es) 2009-08-13

Family

ID=39530785

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009007384A MX2009007384A (es) 2007-01-19 2008-01-10 Formulaciones que contienen ?-lactama con elevada estabilidad en disolucion acuosa.

Country Status (6)

Country Link
US (1) US20100035856A1 (es)
EP (1) EP2124887A2 (es)
BR (1) BRPI0806900A2 (es)
DE (1) DE102007002924A1 (es)
MX (1) MX2009007384A (es)
WO (1) WO2008086971A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2515859B1 (en) * 2009-12-25 2015-09-16 Mahmut Bilgic Rapidly dispersing effervescent formulation
TR200909785A1 (tr) * 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
US8614315B2 (en) 2009-12-25 2013-12-24 Mahmut Bilgic Cefdinir and cefixime formulations and uses thereof
WO2011139252A2 (en) * 2010-05-04 2011-11-10 Mahmut Bilgic Efervescent formulations comprising cefdinir
DE102014012022A1 (de) * 2014-08-13 2016-02-18 Clariant International Ltd. Organische Ammoniumsalze von anionischen Pestiziden
CN112587481B (zh) * 2020-12-28 2022-03-15 成都中牧生物药业有限公司 一种弱碱性阿莫西林可溶性粉及其制备方法
CN114917223B (zh) * 2022-06-02 2023-10-27 成都倍特药业股份有限公司 一种注射用苯唑西林钠药物组合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1466857A (en) 1973-07-12 1977-03-09 Beecham Group Ltd Urea tablets
US4036968A (en) * 1973-07-12 1977-07-19 Beecham Group Limited Pharmaceutical tablet
US4248780A (en) * 1979-08-21 1981-02-03 Canada Packers Limited Process for preparing ampicillin
JPH02124822A (ja) 1988-11-02 1990-05-14 Eisai Co Ltd セファロスポリン含有注射用組成物
JP2761005B2 (ja) 1988-11-02 1998-06-04 エーザイ株式会社 セファロスポリン含有注射用組成物
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
EP0953569A1 (en) * 1998-04-29 1999-11-03 Gist-Brocades B.V. Preparation of beta-lactam antibiotics in the presence of urea or amide
GB0313913D0 (en) * 2003-06-16 2003-07-23 Beecham Pharm Pte Ltd New use
JP2006527726A (ja) * 2003-06-16 2006-12-07 グラクソ グループ リミテッド アモキシシリンおよびクラブラン酸塩を含む医薬製剤

Also Published As

Publication number Publication date
WO2008086971A9 (de) 2009-12-03
WO2008086971A2 (de) 2008-07-24
US20100035856A1 (en) 2010-02-11
BRPI0806900A2 (pt) 2014-04-29
WO2008086971A3 (de) 2008-09-25
EP2124887A2 (de) 2009-12-02
DE102007002924A1 (de) 2008-07-24

Similar Documents

Publication Publication Date Title
WO2010078324A3 (en) Companion animal compositions including lipoic acid and methods of use thereof
MX2009007384A (es) Formulaciones que contienen ?-lactama con elevada estabilidad en disolucion acuosa.
AP2414A (en) Fungicidal aqueous compositions for seed treatment.
MY155418A (en) Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
WO2010090860A3 (en) Methods and compositions for treating bacterial infection
EP2397147A4 (en) PROPHYLACTIC AND / OR THERAPEUTIC ANIMAL FEEDING OF DISEASES DUE TO CLOSTRIDIUM BACTERIA OF DOMESTIC ANIMAL AND ANTI-CLOSTRIDIUM AGENT
WO2009026166A3 (en) Antiinfective flavonol compounds and methods of use thereof
BRPI0909447A2 (pt) Composição, métodos para tratar um indivíduo humano ou animal em necessidade de tal tratamento e para matar ou inibir o crescimento de microrganismos suscetíveis, e, uso de uma composição
RU2012157473A (ru) Способ выявления или лечения реакции "трансплантат против хозяина"
WO2008133894A3 (en) Application of glycerin for improved livestock production
MX2012003732A (es) Composiciones de dibromomalonamida y su uso como biocidas.
EA201000854A1 (ru) Применение эдта и ее солей для профилактики и лечения дизентерии свиней и усиления эффектов антибиотиков, проявляющихся при этом заболевании
WO2010074936A3 (en) Enzastaurin for the treatment of cancer
MX2012003739A (es) Composicones de dibromomalonamida y su uso como biocidas.
EP2110128A4 (en) USE OF PARTICULATE ANTIBACTERIAL COMPOUNDS FROM ALLIACEAE AS NATURAL ADDITIVES FOR ANIMAL FEED
WO2008087562A8 (en) Methods and compositions for modulating the mirna pathway
WO2013067545A3 (en) Compositions and methods for eradication of odors
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
WO2009011910A3 (en) Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment
RS54140B1 (en) USE OF 24-ORDER
BRPI0520510A2 (pt) composições antimicrobiais e seus processos associados
BRPI1008356A2 (pt) "sal de adição ácido de udenafil, respectivo método de preparação e composição farmacêutica"
MY157007A (en) Novel possibility of controlling giardiosis
MX2012003738A (es) Composiciones de dibromomalonamida y su uso como biocidas.
WO2006123164A3 (en) Lps-binding and bactericidal cytokines and interferons